Medtronic PLC | Key People and Executives
Omar S. Ishrak
Chairman & Chief Executive Officer
Scott C. Donnelly
Independent Director
Denise M. O'Leary
Independent Director
Randall J. Hogan
Independent Director
Robert Charles Pozen
Independent Director
Kendall J. Powell
Independent Director
Craig Arnold
Independent Director
Richard H. Anderson
Lead Independent Director
Shirley Ann Jackson
Independent Director
James T. Lenehan
Independent Director
Michael O. Leavitt
Independent Director
Elizabeth G. Nabel
Independent Director
Omar S. Ishrak
Chairman & Chief Executive Officer
Mark Ploof
Senior Vice President-Global Operations
Karen L. Parkhill
Chief Financial Officer & Executive Vice President
Richard E. Kuntz
Chief Scientific, Clinical & Regulatory Officer
Alejandro Galindo
VP & President-Intensive Insulin Management
Laura Mauri
Vice President
Michael J. Coyle
Group President-Cardiac & Vascular Group
Geoffrey Straub Martha
Executive VP & President-Restorative Therapies
Robert J. W. ten Hoedt
President-Europe, Middle East & Africa Region
Ryan Weispfenning
Head-Investor Relations
Fernando Vivanco
Senior Director-Corporate Communications
Carol A. Surface
Chief Human Resources Officer & Senior VP
Bradley E. Lerman
Secretary, Senior Vice President & General Counsel
Scott C. Donnelly
Independent Director
Denise M. O'Leary
Independent Director
Randall J. Hogan
Independent Director
Robert Charles Pozen
Independent Director
Kendall J. Powell
Independent Director
Craig Arnold
Independent Director
Richard H. Anderson
Lead Independent Director
Shirley Ann Jackson
Independent Director
James T. Lenehan
Independent Director
Michael O. Leavitt
Independent Director
Elizabeth G. Nabel
Independent Director
| Address |
20 On Hatch
Dublin Dublin 2
Ireland
|
|
Employees
|
- |
| Website |
http://www.medtronic.com |
| Updated |
07/08/2019 |
| Medtronic Plc is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. |
